Fate Therapeutics FATE
Last Price
52 Week Range
$0.66 - $1.94
Next Earnings Date
Mar 04 2026
Next Earnings Date
Mar 04 2026
Last Price
FATE Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Fate Therapeutics, Inc. | 8-K | November 13, 2025 | |
Fate Therapeutics, Inc. | 10-Q | November 13, 2025 | |
Fate Therapeutics, Inc. | 8-K | October 27, 2025 | |
Fate Therapeutics, Inc. | 8-K | October 14, 2025 | |
Fate Therapeutics, Inc. | 8-K | August 12, 2025 | |
Fate Therapeutics, Inc. | 10-Q | August 12, 2025 | |
Fate Therapeutics, Inc. | 8-K | May 30, 2025 | |
Fate Therapeutics, Inc. | 10-Q | May 13, 2025 | |
Fate Therapeutics, Inc. | 8-K | May 13, 2025 | |
Fate Therapeutics, Inc. | ARS | April 17, 2025 | |
Fate Therapeutics, Inc. | DEF 14A | April 17, 2025 | |
Fate Therapeutics, Inc. | DEFA14A | April 17, 2025 | |
Fate Therapeutics, Inc. | PRE 14A | April 7, 2025 | |
Fate Therapeutics, Inc. | 8-K | March 5, 2025 | |
Fate Therapeutics, Inc. | 10-K | March 5, 2025 | |
Fate Therapeutics, Inc. | 8-K | January 6, 2025 | |
Fate Therapeutics, Inc. | 8-K | November 29, 2024 | |
Fate Therapeutics, Inc. | 10-Q | November 12, 2024 | |
Fate Therapeutics, Inc. | 8-K | November 12, 2024 | |
Fate Therapeutics, Inc. | 8-K | August 30, 2024 | |
Fate Therapeutics, Inc. | 8-K | August 13, 2024 | |
Fate Therapeutics, Inc. | 10-Q | August 13, 2024 | |
Fate Therapeutics, Inc. | 8-K | July 31, 2024 | |
Fate Therapeutics, Inc. | 8-K | June 10, 2024 | |
Fate Therapeutics, Inc. | 8-K | June 7, 2024 | |
Fate Therapeutics, Inc. | 8-K | May 31, 2024 | |
Fate Therapeutics, Inc. | 8-K | May 9, 2024 | |
Fate Therapeutics, Inc. | 8-K | May 9, 2024 | |
Fate Therapeutics, Inc. | 10-Q | May 9, 2024 | |
Fate Therapeutics, Inc. | ARS | April 26, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.